Ken Griffin Ab Cellera Biologics Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$2.73 - $4.73 $30,849 - $53,449	-11,300 Reduced 14.69%	65,600 $194,000
Q1 2024 May 15, 2024	SELL	$4.29 - $5.97 $230,373 - $320,589	-53,700 Reduced 41.12%	76,900 $348,000
Q4 2023 Feb 14, 2024	BUY	$3.91 - $5.93 $195,500 - $296,500	50,000 Added 62.03%	130,600 $745,000
Q3 2023 Nov 14, 2023	BUY	$4.6 - $7.95 $25,299 - $43,725	5,500 Added 7.32%	80,600 $370,000
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $21,508 - $28,842	3,800 Added 5.33%	75,100 $485,000
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $929,832 - $1.42 Million	-127,200 Reduced 64.08%	71,300 $537,000
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $194,340 - $297,660	-20,500 Reduced 9.36%	198,500 $2.01 Million
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $684,480 - $1.02 Million	-74,400 Reduced 25.36%	219,000 $2.17 Million

167

110M

239K

200K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $776M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.